Back
Revance Therapeutics Vs. Astrana Health Industry Stock Comparison
Sell
4
RVNC
Revance Therapeutics
Last Price:
4.13
Seasonality Move:
7.02%
Sell
18
ASTH
Astrana Health
Last Price:
42.9200
Seasonality Move:
23.17%
Sell
4
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $3.44. The Score for RVNC is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
18
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy, Sell or Hold?
- The current Astrana Health [ASTH] share price is $46.8100. The Score for ASTH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- ASTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $3.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.
ASTH Stock Price Chart
What is Astrana Health's stock price today?
-
The Astrana Health share price today is $46.8100
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing slight selling pressure.
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 22.01 | Sell |
Chaikin Money Flow: | -4360846 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.71 - 5.93) | Sell |
Bollinger Bands (100): | (3.48 - 6.32) | Sell |
ASTH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.22 | Sell |
Relative Strength Index (14 RSI): | 31.55 | Sell |
Chaikin Money Flow: | -120939 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.9492 - 60.3292) | Sell |
Bollinger Bands (100): | (44.5893 - 56.9893) | Sell |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.26 | Sell |
20-day SMA: | 5.33 | Sell |
50-day SMA: | 5.62 | Sell |
200-day SMA: | 4.66 | Sell |
8-day EMA: | 4.89 | Sell |
20-day EMA: | 5.25 | Sell |
50-day EMA: | 5.33 | Sell |
200-day EMA: | 6.2 | Sell |
ASTH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.86 | Sell |
20-day SMA: | 56.32 | Sell |
50-day SMA: | 55.22 | Sell |
200-day SMA: | 45.24 | Buy |
8-day EMA: | 52.97 | Sell |
20-day EMA: | 55 | Sell |
50-day EMA: | 54.44 | Sell |
200-day EMA: | 46.93 | Sell |
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.63 per share.
Astrana Health Earnings Growth & ASTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.13 per share.
Revance Therapeutics Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Astrana Health Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |